Melanoma advocates hope a new Pharmac proposal will take the pressure off patients. 

Consultation's open on whether to expand access to two immunotherapy medicines for people with stage 3b and 4 melanoma from May.

Used pre-surgery, nivolumab and ipilimumab can lower the chance of cancers returning. 

Medical Oncologist and Melanoma Specialist Dr Gareth Rivalland tells Ryan about the difference it will make.